ACT 1 PROJ 2 TARGETED HIGH-FREQUENCY ULTRASOUND-CONTRAST AGENT IMAGING
行动 1 项目 2 定向高频超声造影剂成像
基本信息
- 批准号:7959175
- 负责人:
- 金额:$ 23.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcousticsAcuteAreaArterial Fatty StreakBindingBiological MarkersBlood flowCardiovascular DiseasesCessation of lifeClassificationComputer Retrieval of Information on Scientific Projects DatabaseContrast MediaCoronaryCoronary AngiographyDiseaseEncapsulatedFilipinoFrequenciesFundingGeneral PopulationGrantHawaiiHawaiian populationHealth Care CostsHeartHospitalizationImageInflammationInstitutionLeukocytesLigandsLipidsMedicalMicrobubblesNutrientOutcomes ResearchPatientsPhysiologicalRecommendationResearchResearch PersonnelResourcesRiskRuptureShadowing (Histology)Signal TransductionSiteSourceStagingStimulusSystemUltrasonographyUnited StatesUnited States National Institutes of HealthVascular remodelingdiet and exercisehigh riskimaging modalitymolecular imagingmortalityneovascularizationpreventresponseshear stresssudden cardiac deathtwo-dimensionalvasa vasorum
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Cardiovascular disease is a leading cause of illness and death in the United States and in Hawaii. Upon closer examination of the mortality rate from cardiovascular disease in Hawaii, it is clear that Filipinos and Native Hawaiians have a disproportionally higher mortality rate than the general population. Moreover, cardiovascular disease is a responsible for a significant portion of the state health care costs from hospitalizations. Sudden cardiac death and acute heart often occur without warning and these complications are typically associated with a plaque rupture corresponding to advanced stages of coronary atherosclerotic disease. Recommendations in terms in diet and exercise have been developed to prevent the onset of atherosclerotic disease but less effort has been made to aid patients who may be at risk for vulnerable plaque rupture. Coronary angiography has limitations as it does not allow for inspection of the vessel wall and can only determine narrowing of the luminal. Intravascular ultrasound (IVUS) provides a two dimensional cross sections view of the arterial wall and offers some ability to determine lumen and vessels areas. However, severe limitations exist in the classifications of plaques. The high frequency signal may be confused with acoustic shadowing aspects. The mechanisms of plaque rupture are not well understood and currently no imaging modality currently exists which can robustly detect vulnerable plaques.
Vulnerable plaques are characterized by a large lipid core with a thin and inflamed fibrous cap. Low endothelial shear stress from the surrounding blood flow can serve as stimulus for the progression and differentiation of an early fibroatheroma to a high risk plaque. It has been hypothesized that vasa vasorum which supplies nutrients to the adventia may serve as a means for which white blood cells migrate into the lining of the wall. Subsequently, expansive vascular remodeling can occur within these plaques. The addition of molecular imaging capabilities to IVUS probes would provide an improvement in detecting biomarkers for plaque rupture such as neovascularization and inflammation. Targeted ultrasound contrast agents are encapsulated microbubbles with attached ligands which allow them to bind to specific diseased sites. The center frequency of IVUS probes (35-50 MHz) is much higher than conventional diagnostic ultrasound systems. We investigate the targeting efficacy in physiological flow conditions for large vessels and the optimal acoustical response of targeted agents at high frequency.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
心血管疾病是美国和夏威夷疾病和死亡的主要原因。仔细检查夏威夷心血管疾病的死亡率后发现,菲律宾人和夏威夷原住民的死亡率明显高于一般人群。此外,心血管疾病占州住院医疗费用的很大一部分。 心源性猝死和急性心脏病常常在毫无征兆的情况下发生,这些并发症通常与冠状动脉粥样硬化疾病晚期的斑块破裂有关。 已经制定了饮食和运动方面的建议来预防动脉粥样硬化疾病的发生,但为帮助可能面临易损斑块破裂风险的患者所做的努力较少。 冠状动脉造影有局限性,因为它不允许检查血管壁,只能确定管腔的狭窄情况。 血管内超声 (IVUS) 提供动脉壁的二维横截面视图,并具有确定管腔和血管面积的能力。 然而,斑块的分类存在严重的局限性。 高频信号可能与声学阴影方面相混淆。 斑块破裂的机制尚不清楚,目前尚不存在可以可靠地检测易损斑块的成像方式。
易损斑块的特征是具有大的脂质核心和薄且发炎的纤维帽。来自周围血流的低内皮剪切应力可以刺激早期纤维粥样斑块进展和分化为高风险斑块。 据推测,向外膜提供营养的滋养血管可能是白细胞迁移到血管壁内层的一种手段。 随后,这些斑块内可能发生扩张性血管重塑。 IVUS 探针增加分子成像功能将改善斑块破裂生物标志物(如新血管形成和炎症)的检测。 靶向超声造影剂是带有配体的封装微泡,使它们能够结合到特定的病变部位。 IVUS 探头的中心频率 (35-50 MHz) 远高于传统诊断超声系统。 我们研究了大血管生理流动条件下的靶向功效以及靶向药物在高频下的最佳声学响应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John A Allen其他文献
John A Allen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John A Allen', 18)}}的其他基金
Developing GPR37 activators as non-opioid pain therapeutics
开发 GPR37 激活剂作为非阿片类疼痛疗法
- 批准号:
10453930 - 财政年份:2022
- 资助金额:
$ 23.4万 - 项目类别:
Kinetics of Ligand Binding in Dopamine D1 Receptor Biased Signaling
多巴胺 D1 受体偏向信号传导中配体结合动力学
- 批准号:
9973218 - 财政年份:2019
- 资助金额:
$ 23.4万 - 项目类别:
ACT 1 PROJ 2 TARGETED HIGH-FREQUENCY ULTRASOUND-CONTRAST AGENT IMAGING
行动 1 项目 2 定向高频超声造影剂成像
- 批准号:
8357170 - 财政年份:2011
- 资助金额:
$ 23.4万 - 项目类别:
ACT 1 PROJ 2 TARGETED HIGH-FREQUENCY ULTRASOUND-CONTRAST AGENT IMAGING
行动 1 项目 2 定向高频超声造影剂成像
- 批准号:
8166176 - 财政年份:2010
- 资助金额:
$ 23.4万 - 项目类别:
ACT 1: PROJ 2: TARGETED HIGH-FREQUENCY ULTRASOUND-CONTRAST AGENT IMAGING
行动 1:项目 2:定向高频超声造影剂成像
- 批准号:
7715306 - 财政年份:2008
- 资助金额:
$ 23.4万 - 项目类别:
ACT 1: PROJ 2: TARGETED HIGH-FREQUENCY ULTRASOUND-CONTRAST AGENT IMAGING
行动 1:项目 2:定向高频超声造影剂成像
- 批准号:
7561547 - 财政年份:2007
- 资助金额:
$ 23.4万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Mentored Patient-Oriented Research of Novel Mechanisms Linking Pain, Sleep-Wake Patterns, and Autonomic Activity in Rheumatic Diseases
指导以患者为导向的风湿性疾病中疼痛、睡眠-觉醒模式和自主活动相关新机制的研究
- 批准号:
10592158 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
The neural mechanisms and mnemonic consequences of sound processing during sleep
睡眠期间声音处理的神经机制和记忆后果
- 批准号:
10734969 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
Development of A Focused Ultrasound Device for Noninvasive, Peripheral Nerve Blockade to Manage Acute Pain
开发用于非侵入性周围神经阻断来治疗急性疼痛的聚焦超声装置
- 批准号:
10740796 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
Advancing Methods for MR-guided Focused Ultrasound Hyperthermia for Head and Neck Cancer
推进 MR 引导聚焦超声热疗治疗头颈癌的方法
- 批准号:
10738459 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
Super Resolution Ultrasound Imaging of Vasa Vasorum to Characterize the Progression of Atherosclerotic Plaques and Predict Rupture Vulnerability
血管超分辨率超声成像可表征动脉粥样硬化斑块的进展并预测破裂脆弱性
- 批准号:
10557917 - 财政年份:2022
- 资助金额:
$ 23.4万 - 项目类别: